Secondary bacterial pneumonia frequently claimed the lives of victims during the devastating
1918 influenza A virus pandemic. Little is known about the viral factors contributing to the …

Cell surface mucin glycoproteins are highly expressed by all mucosal tissues, yet their
physiological role is currently unknown. We hypothesized that cell surface mucins protect …

With the constant threat of emergence of a novel influenza virus pandemic, there must be
continued evaluation of the molecular mechanisms that contribute to virulence. Although the …

The influenza A virus PB1-F2 protein has been implicated as a virulence factor, but the
mechanism by which it enhances pathogenicity is not understood. The PB1 gene segment of the …

The ability for a host to recognize infection is critical for virus clearance and often begins with
induction of inflammation. The PB1-F2 of pathogenic influenza A viruses (IAV) contributes …

Type I Interferons (IFN-Is) are a family of cytokines which play a major role in inhibiting viral
infection. Resultantly, many viruses have evolved mechanisms in which to evade the IFN-I …

The role of respiratory viruses in the transmission of Streptococcus pneumoniae is poorly
understood. Key questions, such as which serotypes are most fit for transmission and disease …

Secondary bacterial infections are a leading cause of illness and death during epidemic and
pandemic influenza. Experimental studies suggest a lethal synergism between influenza …

Superinfections from Staphylococcus aureus following influenza are an increasing concern.
We assessed several laboratory and clinical strains in a mouse coinfection model with …

The inflammasome NLRP3 is activated by pathogen associated molecular patterns (PAMPs)
during infection, including RNA and proteins from influenza A virus (IAV). However, chronic …